chr14-102923789-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_ModeratePP5_Moderate
The ENST00000299155.10(AMN):c.122C>T(p.Thr41Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000049 in 1,612,640 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. T41T) has been classified as Likely benign.
Frequency
Consequence
ENST00000299155.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AMN | NM_030943.4 | c.122C>T | p.Thr41Ile | missense_variant | 2/12 | ENST00000299155.10 | NP_112205.2 | |
AMN | XM_011537202.4 | c.-41C>T | 5_prime_UTR_variant | 2/12 | XP_011535504.1 | |||
AMN | XM_011537203.4 | c.-41C>T | 5_prime_UTR_variant | 2/12 | XP_011535505.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AMN | ENST00000299155.10 | c.122C>T | p.Thr41Ile | missense_variant | 2/12 | 1 | NM_030943.4 | ENSP00000299155 | P1 | |
AMN | ENST00000541086.5 | n.868C>T | non_coding_transcript_exon_variant | 1/11 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152240Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000161 AC: 4AN: 248754Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135282
GnomAD4 exome AF: 0.0000514 AC: 75AN: 1460400Hom.: 0 Cov.: 31 AF XY: 0.0000468 AC XY: 34AN XY: 726528
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152240Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74374
ClinVar
Submissions by phenotype
Imerslund-Grasbeck syndrome type 2 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 01, 2003 | - - |
Imerslund-Grasbeck syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 15, 2023 | This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 41 of the AMN protein (p.Thr41Ile). This variant is present in population databases (rs119478058, gnomAD 0.006%). This missense change has been observed in individuals with clinical features of Imerslund-GraÃàsbeck syndrome (PMID: 12590260, 22929189). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 4770). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt AMN protein function. Experimental studies have shown that this missense change affects AMN function (PMID: 30523278). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at